Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SATLANTIS designs and manufactures high performance Earth observation payloads for small satellites.
Samplix's Xdrop® technology is a proprietary droplet-based platform designed for single-molecule encapsulation.
Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
DELMIC is a company that produces correlative light and electron microscopy solutions.
FacePhi is the spanish company in biometric solutions for identity verification.
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Pilot Photonics develops comb source laser technology for the communications, space, and industrial markets.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
CH-Bioforce is the developer of the best biomass fractionation technology in the world.
K-Ryole is a privately held company that manufactures smart electric bike trailer.
BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.
Wavepiston converts the energy in the waves to produce clean power and clean water all over the world.
AI Healthtech company developing platform to aggregate structured, contextualized data for applied precision medicine and research.
IBEX X-ray detector technology adds materials information to silicon based detectors.
React4life Srl is an Italian biotech company producing MIVO® (Multi In Vitro Organ), the next generation of organ-on-a-chip.
Finboot is a software company that provides green supply chain management solutions for manufacturing companies.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
SolarGaps is a smart blinds that generate electricity.
Cynny business was acquired by Morphcast Inc. USA
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.
Silk-fibroin tissue engineering technology platform
HAWK Biosystems is a cancer diagnostics platform.
Norlase is an ophthalmic laser manufacturer specializing in laser technology for the treatment of retinal and glaucoma disorders.
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
EISMEA has invested in 616 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Biotechnology, Health Care, Manufacturing, Medical Device, Health Diagnostics. The firm invests across 52 different industry categories.
Among tracked funding rounds, Norlase received $20.9M in a Debt Financing round. EISMEA's total known invested capital is $2.2B.
EISMEA's average investment size is $5.1M across its portfolio of 616 companies.
Recent EISMEA portfolio additions include SATLANTIS, Samplix, Elypta, DELMIC, FacePhi. These companies were founded in 2020 or later.